GlassScriptPhysician profile
Bryan P Carter
NPI 1578563599
$1,600.05
in general payments reported to CMS, 2019-2025
25 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $277 · 2023: $384 · 2024: $459 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $285.26 | 2022-2025 | |
| Biosense Webster, INC. | $150.29 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $115.71 | 2023-2024 | Watchman Flx, Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $113.54 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $94.35 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $89.82 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $71.06 | 2022-2025 | Brilinta, Lokelma |
| Abbott Laboratories | $68.28 | 2021-2025 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.57 | 2021-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.66 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $55.58 | 2022-2025 | Verquvo |
| Medtronic, INC. | $49.84 | 2022-2024 | Reveal Linq |
| Cvrx, INC. | $49.04 | 2024-2025 | Barostim Neo System |
| Biotronik INC. | $46.82 | 2021-2025 | Biomonitor, Amvia Edge, Renamic Neo |
| Kiniksa Pharmaceuticals, LTD. | $46.70 | 2023 | Arcalyst |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $41.32 | 2021-2023 | Nexletol |
| Impulse Dynamics (USA) INC. | $41.04 | 2022-2025 | Optimizer |
| Novo Nordisk INC | $36.38 | 2022-2025 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $24.80 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $22.64 | 2025 | |
| Angiodynamics, INC. | $20.53 | 2024 | Venacure 1470 Pro |
| Irhythm Technologies, INC. | $17.26 | 2023 | Zio Xt Patch |
| Amgen INC. | $14.49 | 2021 | |
| Elutia, INC. | $12.72 | 2022 | |
| Merit Medical Systems INC | $10.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.